Octopus Biosafety (FRA:OCR) 12-1 Month Momentum %: N/A% (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OCR Octopus Biosafety FRA:OCR
7 GF Score
Price €0.13
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety 12-1 Month Momentum %?

Octopus Biosafety FRA:OCR +23.15% 7 12-1 Month Momentum % is N/A% as of Sep. 11, 2026. GuruFocus rates FRA:OCR with a GF Score™ of 7/100. The stock has 2 warning signs investors should review. Among 2,436 Hardware companies, Octopus Biosafety ranks worse than 87.85% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-11), Octopus Biosafety's 12-1 Month Momentum % is N/A%.

The industry rank for Octopus Biosafety's 12-1 Month Momentum % or its related term are showing as below:

FRA:OCR's 12-1 Month Momentum % is not ranked *
in the Hardware industry.
Industry Median: 3.655
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Octopus Biosafety  (FRA:OCR) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Octopus Biosafety 12-1 Month Momentum % Related Terms

FRA:OCR
7GF Score
Octopus Biosafety FRA:OCR
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety  (FRA:OCR) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of N/A% mean?
Octopus Biosafety (FRA:OCR) has a 12-1 Month Momentum % of N/A% as of Sep. 11, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #2140 out of 2436 companies in the Hardware industry, placing it in the top 87.8%.
Is Octopus Biosafety's 12-1 Month Momentum % too high?
Octopus Biosafety's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, Octopus Biosafety ranks #2140 out of 2436 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's 12-1 Month Momentum % compare to DELL and ANET?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2140 out of 2436 companies for 12-1 Month Momentum %. This places Octopus Biosafety in the lower half of its industry. The industry median 12-1 Month Momentum % is 3.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Hardware company?
The median 12-1 Month Momentum % among Hardware companies is 3.66, based on 2,436 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median 12-1 Month Momentum % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (FRA:OCR) has a current 12-1 Month Momentum % of N/A%. The current 12-1 Month Momentum % is N/A%. Octopus Biosafety's overall GF Score™ is 7/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Octopus Biosafety (FRA:OCR), the current 12-1 Month Momentum % is N/A% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
7GF Score

Get the complete analysis for FRA:OCR

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price